Circulating Cell-Free High Mobility Group AT-hook 2 mRNA as a Detection Marker in the Serum of Colorectal Cancer Patients

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22332
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Circulating Cell Free DNA as the Diagnostic Marker for Colorectal Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2018English

Serum CA19-9 as a Marker of Circulating Tumor Cells in First Reflux Blood of Colorectal Cancer Patients

Oncotarget
Oncology
2017English

Serum Expression of Β-Catenin Is a Potential Detection Marker in Patients With Colorectal Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Serum High-Mobility Group Box-1 Protein as a Specific Marker of Severe Abdominal Injury

Critical Care
Critical CareIntensive Care Medicine
2009English

MicroRNA‑98‑5p Prevents Bone Regeneration by Targeting High Mobility Group AT‑Hook 2

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

SpringerPlus
Multidisciplinary
2015English

Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Tight Binding of Natural Polyphenols to the Intrinsically Disordered Mammalian High Mobility Group Protein At-Hook 2

Biophysical Journal
Biophysics
2019English

Detection of Mutations in Circulating Cell‐free DNA in Relation to Disease Stage in Colorectal Cancer

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy